Elevated baseline levels of NfL have been linked to poor cognitive performance and accelerated disease progression, with the rate of change correlating with cognitive changes in patients with AD (Mielke et al., 2019; Mattsson et al., 2019; Raket et al., 2020). The gene discussed is NEFL; the disease is Alzheimer disease.